|
Volumn 32, Issue 12, 1998, Pages 1334-1343
|
Topotecan: A new topoisomerase I inhibiting antineoplastic agent
|
Author keywords
Breast; Cancer; Leukemia; Lung; Ovarian; Topotecan; Uterus
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DNA TOPOISOMERASE INHIBITOR;
DOXORUBICIN;
ETOPOSIDE;
PACLITAXEL;
TOPOTECAN;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LUNG CANCER;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
OVARY CANCER;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
UTERUS CANCER;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DNA TOPOISOMERASES, TYPE I;
ECONOMICS, PHARMACEUTICAL;
ENZYME INHIBITORS;
HUMANS;
NEOPLASMS;
TOPOTECAN;
TREATMENT OUTCOME;
|
EID: 0032425604
PISSN: 10600280
EISSN: None
Source Type: Journal
DOI: 10.1345/aph.18049 Document Type: Review |
Times cited : (26)
|
References (8)
|